Streetbeat News

Legal

SGMO

Levi & Korsinsky has initiated an investigation into Sangamo Therapeutics, Inc. (SGMO) for potential federal securities law violations. This follows Pfizer's decision to return development rights for a hemophilia A gene therapy, impacting Sangamo's commercialization plans.

Portfolio Pulse from

January 09, 2025 | 3:30 pm

CVNA

Levi & Korsinsky has initiated an investigation into Carvana Co. (NYSE:CVNA) for potential violations of federal securities laws following a report by Hindenburg Research.

Portfolio Pulse from

January 09, 2025 | 3:30 pm

AEHR

The Schall Law Firm has announced a class action lawsuit against Aehr Test Systems, Inc. for alleged securities fraud. The lawsuit claims violations of the Securities Exchange Act of 1934. Shareholders who incurred losses between January 9, 2024, and March 24, 2024, are invited to join the case.

Portfolio Pulse from

January 09, 2025 | 3:30 pm

HAS

The Schall Law Firm has announced a class action lawsuit against Hasbro, Inc. for alleged securities fraud. The lawsuit claims violations of the Securities Exchange Act of 1934, targeting investors who purchased Hasbro securities between February 7, 2022, and October 25, 2023. Investors are urged to join the lawsuit by January 13, 2025.

Portfolio Pulse from

January 09, 2025 | 3:30 pm

VICR

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of Vicor Corporation (NASDAQ:VICR) stockholders. Investors who purchased Vicor securities before April 26, 2023, are encouraged to participate in the investigation.

Portfolio Pulse from

January 09, 2025 | 3:15 pm

AKRO

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of Akero Therapeutics, Inc. (NASDAQ:AKRO) stockholders. Investors who purchased Akero securities before September 13, 2022, are encouraged to participate in the investigation.

Portfolio Pulse from

January 09, 2025 | 3:15 pm

IRTC

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against iRhythm Technologies, Inc. (NASDAQ:IRTC) on behalf of investors who purchased securities before January 11, 2022. Investors are encouraged to learn more about the investigation.

Portfolio Pulse from

January 09, 2025 | 3:15 pm

LFCR

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of Lifecore Biomedical, Inc. shareholders who purchased securities before October 7, 2020. Shareholders are encouraged to contact the firm for more information.

Portfolio Pulse from

January 09, 2025 | 3:15 pm

RVNC

A class action lawsuit has been filed against Revance Therapeutics, Inc. (NASDAQ:RVNC) by Bronstein, Gewirtz & Grossman, LLC. The lawsuit alleges violations of federal securities laws for investors who acquired Revance securities between February 29, 2024, and December 6, 2024.

Portfolio Pulse from

January 09, 2025 | 3:15 pm

SAGE

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of investors in Sage Therapeutics, Inc. (NASDAQ:SAGE) who purchased securities before April 12, 2021. Investors are encouraged to participate in the investigation.

Portfolio Pulse from

January 09, 2025 | 3:15 pm